Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,409
Views
21
CrossRef citations to date
0
Altmetric
Back Matter

Prognostic value of CD73 expression in resected colorectal cancer liver metastasis

Nouredin Messaoudia Cancer Axis, Centre de Recherche Du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada;b Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada;c Department of Surgery, University of Antwerp, Antwerp, Belgium;d Department of Surgery, University Hospital of Brussels (UZ Brussel) and Europe Hospitals, Brussels, BelgiumView further author information
,
Isabelle Cousineaua Cancer Axis, Centre de Recherche Du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, CanadaView further author information
,
Elizabeth Arslaniane Department of Pathology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
David Henaulta Cancer Axis, Centre de Recherche Du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, CanadaView further author information
,
David Stephene Department of Pathology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
Franck Vandenbroucke-Menub Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
Michel Dagenaisb Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
Richard Létourneaub Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
Marylène Plasseb Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
André Royb Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
Réal Lapointeb Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
Dirk Ysebaertc Department of Surgery, University of Antwerp, Antwerp, BelgiumView further author information
,
Dominique Trudela Cancer Axis, Centre de Recherche Du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada;e Department of Pathology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
Geneviève Soucye Department of Pathology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaView further author information
,
John Stagga Cancer Axis, Centre de Recherche Du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, CanadaCorrespondence[email protected]
View further author information
&
Simon Turcottea Cancer Axis, Centre de Recherche Du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada;b Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, CanadaCorrespondence[email protected]
View further author information
 show all
Article: 1746138 | Received 26 Jul 2019, Accepted 19 Dec 2019, Published online: 23 Apr 2020

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

David Henault, David Stephen, Pierre-Antoine St-Hilaire, Nouredin Messaoudi, Franck Vandenbroucke-Menu, Eve Simoneau, Zhixia Rong, Marylène Plasse, Richard Létourneau, André Roy, Michel Dagenais, Réal Lapointe, Bich Nguyen, Anne-Marie Mes-Masson, G. Soucy & Simon Turcotte. (2023) Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy. OncoImmunology 12:1.
Read now

Articles from other publishers (20)

Elena Díaz-García, Aldara García-Sánchez, Enrique Alfaro, Cristina López-Fernández, Eva Mañas, Raquel Casitas, Sara Vega, Irene Cano-Pumarega, Francisco García-Río & Carolina Cubillos-Zapata. (2024) Dysregulation in CD39/CD73 Axis May Trigger the Upsurge of the Immune Suppressive Agent Adenosine in OSA Patients. Archivos de Bronconeumología.
Crossref
Dailei Qin, Ran Wei, Kewei Huang, Ruiqi Wang, Honglu Ding, Zehui Yao, Pu Xi & Shengping Li. (2023) Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery. Journal of Cancer Research and Clinical Oncology 149:10, pages 7805-7817.
Crossref
Ralph Saber, David Henault, Nouredin Messaoudi, Rolando Rebolledo, Emmanuel Montagnon, Geneviève Soucy, John Stagg, An Tang, Simon Turcotte & Samuel Kadoury. (2023) Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases. Journal of Translational Medicine 21:1.
Crossref
Niklas Bach, Riekje Winzer, Eva Tolosa, Walter Fiedler & Franziska Brauneck. (2023) The Clinical Significance of CD73 in Cancer. International Journal of Molecular Sciences 24:14, pages 11759.
Crossref
Johanna Bendell, Patricia LoRusso, Michael Overman, Anne M. Noonan, Dong-Wan Kim, John H. Strickler, Sang-We Kim, Stephen Clarke, Thomas J. George, Peter S. Grimison, Minal Barve, Manik Amin, Jayesh Desai, Trisha Wise-Draper, Steven Eck, Yu Jiang, Anis A. Khan, Yuling Wu, Philip Martin, Zachary A. Cooper, Nairouz Elgeioushi, Nancy Mueller, Rakesh Kumar & Sandip Pravin Patel. (2023) First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors. Cancer Immunology, Immunotherapy 72:7, pages 2443-2458.
Crossref
Yun-Shan Lin, Shu-Fen Chiang, Chia-Yi Chen, Wei-Ze Hong, Tsung-Wei Chen, William Tzu-Liang Chen, Tao-Wei Ke, Pei-Chen Yang, Ji-An Liang, An‑Cheng Shiau, K. S. Clifford Chao & Kevin Chih-Yang Huang. (2023) Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation. Cancer Immunology, Immunotherapy 72:7, pages 2283-2297.
Crossref
Zoya Kurago, Gang Guo, Huidong Shi, Roni J. Bollag, Michael W. Groves, J. Kenneth Byrd & Yan Cui. (2023) Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy. Frontiers in Immunology 14.
Crossref
Ioannis M. Koukourakis, Kalliopi Platoni, Dina Tiniakos, Vassilis Kouloulias & Anna Zygogianni. (2023) Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review. Current Issues in Molecular Biology 45:5, pages 4495-4517.
Crossref
Jim Li, Lijing Chen, Roland J. Billedeau, Timothy F. Stanton, John T. P. Chiang, Clarissa C. Lee, Weiqun Li, Susanne Steggerda, Ethan Emberley, Matthew Gross, Deepthi Bhupathi, Xiaoying Che, Jason Chen, Rosalyn Dang, Tony Huang, Yong Ma, Andrew MacKinnon, Amani Makkouk, Gisele Marguier, Silinda Neou, Natalija Sotirovska, Sandra Spurlock, Jing Zhang, Winter Zhang, Michael van Zandt, Lin Yuan, Jennifer Savoy, Francesco Parlati & Eric B. Sjogren. (2022) Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity . Journal of Medicinal Chemistry 66:1, pages 345-370.
Crossref
Célia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, David Allard, Pavel Chrobak, Bertrand Allard, Sandra Pommey, Nouredin Messaoudi, Yannic McNicoll, Geneviève Soucy, Secil Koseoglu, Ricard Masia, Andrew C. Lake, Heewon Seo, Christopher B. Eeles, Neha Rohatgi, Simon C. Robson, Simon Turcotte, Benjamin Haibe-Kains & John Stagg. (2023) CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer. Cancer Immunology Research 11:1, pages 56-71.
Crossref
Dongchan Kim, Bhavya Gupta & Geoffrey Yuet Mun Wong. (2023) Prognostic circulating proteomic biomarkers in colorectal liver metastases. Computational and Structural Biotechnology Journal 21, pages 2129-2136.
Crossref
Serkan GÖKTUNA. (2022) CHARACTERIZATION OF DIFFERENTIAL EXPRESSION PATTERNS OF THE EXTRACELLULAR PURINERGIC ENZYMES IN COLORECTAL CANCER. Trakya University Journal of Natural Sciences 23:2, pages 177-184.
Crossref
Gabriela Roliano, Juliana Azambuja, Veronica Brunetto, Hannah Butterfield, Antonio Kalil & Elizandra Braganhol. (2022) Colorectal Cancer and Purinergic Signalling: An Overview. Cancers 14:19, pages 4887.
Crossref
Nouredin Messaoudi, David Henault, David Stephen, Isabelle Cousineau, Eve Simoneau, Zhixia Rong, Richard Létourneau, Marylène Plasse, Michel Dagenais, André Roy, Réal Lapointe, Franck Vandenbroucke-Menu, Rastislav Kunda, Dirk Ysebaert, Geneviève Soucy, John Stagg, Peter Vermeulen & Simon Turcotte. (2022) Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns. British Journal of Cancer 126:9, pages 1329-1338.
Crossref
Brecht Decraene, Yihan Yang, Frederik De Smet, Abhishek D. Garg, Patrizia Agostinis & Steven De Vleeschouwer. (2022) Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma. Genes & Immunity 23:1, pages 1-11.
Crossref
Ji-Yoon Noh, In Pyo Lee, Na Rae Han, Miok Kim, Yong Ki Min, Sang-Yeop Lee, Sung Ho Yun, Seung Il Kim, Tamina Park, Hyunmin Chung, Daeui Park & Chang Hoon Lee. (2022) Additive Effect of CD73 Inhibitor in Colorectal Cancer Treatment With CDK4/6 Inhibitor Through Regulation of PD-L1. Cellular and Molecular Gastroenterology and Hepatology 14:4, pages 769-788.
Crossref
Elham Baghbani, Saeed Noorolyai, Dariush Shanehbandi, Ahad Mokhtarzadeh, Leili Aghebati-Maleki, Vahid Khaze Shahgoli, Oronzo Brunetti, Shima Rahmani, Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Nicola Silvestris & Behzad Baradaran. (2021) Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints. Life Sciences 282, pages 119826.
Crossref
Oliver Kepp, Lucillia Bezu, Takahiro Yamazaki, Francesco Di Virgilio, Mark J Smyth, Guido Kroemer & Lorenzo Galluzzi. (2021) ATP and cancer immunosurveillance. The EMBO Journal 40:13.
Crossref
Roberta Turiello, Mariaelena Capone, Diana Giannarelli, Elva Morretta, Maria Chiara Monti, Gabriele Madonna, Domenico Mallardo, Lucia Festino, Rosa Azzaro, Mitchell P Levesque, Laurence Imhof, Benjamin Weide, Teresa Amaral, Marc Chevrier, Antje Sucker, Piotr Rutkowski, Dirk Schadendorf, Celeste Lebbe, Jason John Luke, Kilian Wistuba-Hamprecht, Reinhard Dummer, Aldo Pinto, Silvana Morello & Paolo A Ascierto. (2020) Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy. Journal for ImmunoTherapy of Cancer 8:2, pages e001689.
Crossref
Roberta Turiello, Aldo Pinto & Silvana Morello. (2020) CD73: A Promising Biomarker in Cancer Patients. Frontiers in Pharmacology 11.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.